Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-arm, Open-label Study To Assess The Immunogenicity, Safety, And Efficacy Of Etanercept Manufactured Using The High Capacity Process Administered To Subjects With Rheumatoid Arthritis

NCT02378506 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT02378506
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02378506 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-arm, Open-label Study To Assess The Immunogenicity, Safety, And Efficacy Of Etanercept Manufactured Using The High Capacity Process Administered To Subjects With Rheumatoid Arthritis
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2015
Completion date
June 30, 2016
Enrollment
188 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

arthritis, rheumatoid